Watershed Asset Management L.L.C. Invests $462,000 in DaVita Inc. $DVA

Watershed Asset Management L.L.C. bought a new stake in DaVita Inc. (NYSE:DVA) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 3,003 shares of the company’s stock, valued at approximately $462,000.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Heartland Bank & Trust Co purchased a new position in shares of DaVita in the 1st quarter worth about $351,000. Kera Capital Partners Inc. acquired a new position in shares of DaVita in the 1st quarter valued at about $218,000. Bessemer Group Inc. grew its holdings in shares of DaVita by 3.9% during the 1st quarter. Bessemer Group Inc. now owns 2,962 shares of the company’s stock worth $456,000 after purchasing an additional 110 shares during the period. Allspring Global Investments Holdings LLC purchased a new stake in shares of DaVita during the 1st quarter worth about $251,000. Finally, D.A. Davidson & CO. acquired a new stake in DaVita during the 1st quarter worth approximately $251,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Stock Up 1.2%

NYSE DVA opened at $236.93 on Friday. DaVita Inc. has a fifty-two week low of $101.00 and a fifty-two week high of $239.64. The business has a 50 day moving average price of $209.94 and a two-hundred day moving average price of $164.49. The stock has a market cap of $15.21 billion, a PE ratio of 21.98, a P/E/G ratio of 0.77 and a beta of 0.88.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $2.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.33 by $0.54. DaVita had a net margin of 5.65% and a negative return on equity of 270.37%. The company had revenue of $3.42 billion for the quarter, compared to analyst estimates of $3.36 billion. During the same quarter last year, the firm posted $2.00 earnings per share. The business’s quarterly revenue was up 6.0% on a year-over-year basis. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. Sell-side analysts anticipate that DaVita Inc. will post 15.07 EPS for the current fiscal year.

Insider Buying and Selling at DaVita

In other DaVita news, insider Kathleen Alyce Waters sold 15,405 shares of the business’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $208.40, for a total value of $3,210,402.00. Following the transaction, the insider owned 109,194 shares in the company, valued at $22,756,029.60. The trade was a 12.36% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Joel Ackerman sold 51,471 shares of the company’s stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $192.10, for a total transaction of $9,887,579.10. Following the completion of the transaction, the chief financial officer directly owned 132,434 shares of the company’s stock, valued at approximately $25,440,571.40. The trade was a 27.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.90% of the company’s stock.

Analyst Ratings Changes

DVA has been the subject of several research reports. Deutsche Bank Aktiengesellschaft upgraded shares of DaVita from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $126.00 to $220.00 in a research note on Wednesday, May 6th. Zacks Research downgraded shares of DaVita from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 6th. TD Cowen lifted their target price on shares of DaVita from $144.00 to $201.00 and gave the company a “hold” rating in a report on Monday, May 11th. UBS Group upped their price target on shares of DaVita from $235.00 to $270.00 and gave the stock a “buy” rating in a research report on Friday, July 10th. Finally, Truist Financial raised their price objective on DaVita from $205.00 to $250.00 and gave the company a “hold” rating in a research report on Tuesday. Two research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $216.50.

DaVita Company Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.